Alibaba Health Information Technology Limited
ALBBY · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $31 | $27 | $27 | $21 |
| % Growth | 13.2% | 1% | 30.1% | – |
| Cost of Goods Sold | $23 | $21 | $21 | $16 |
| Gross Profit | $7 | $6 | $6 | $4 |
| % Margin | 24.3% | 21.8% | 21.3% | 20% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $3 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $2 | $2 | $2 | $2 |
| Other Operating Expenses | $2 | $2 | $3 | $2 |
| Operating Expenses | $6 | $5 | $6 | $5 |
| Operating Income | $2 | $1 | -$0 | -$1 |
| % Margin | 5.2% | 2.4% | -0.1% | -5.3% |
| Other Income/Exp. Net | -$0 | $0 | $1 | $0 |
| Pre-Tax Income | $2 | $1 | $1 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $1 | $1 | $1 | -$0 |
| % Margin | 4.7% | 3.3% | 2% | -1.3% |
| EPS | 1.78 | 1.25 | 0.79 | -0.39 |
| % Growth | 42.4% | 58.2% | 302.6% | – |
| EPS Diluted | 1.78 | 1.25 | 0.79 | -0.39 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $2 | $1 | -$0 | -$0 |
| % Margin | 5.3% | 3.7% | -0.1% | -0.9% |